CF patients with a homozygous deletion in the ACE gene (D/D genotype) tend to experience severe, early-onset respiratory disease and increased inflammation, while patients without this deletion (I/I genotype) generally exhibit better lung function due to reduced ACE activity [63]. The gene discussed is ACE; the disease is respiratory system disorder.